MedTrace Logo

Effect of Aerobics on Physical and Mental Health in Polycystic Ovary Syndrome

NCT05577949 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 176

Last updated 2022-10-13

No results posted yet for this study

Summary

Polycystic ovary is one of the most common metabolic and endocrine disorders in women of reproductive age group. The Rotterdam criteria are used internationally for its diagnosis. It has been reported that 57% of these women have at least one mental disorder. There is no health without mental health and it is fundamental to the good health and well-being of an individual. Women with PCOS are at risk of a wide range of significant psychological difficulties including depression, anxiety, eating disorders, sexual disorders, low self-esteem, poor body image, and overall low quality of life. In the healthy population, exercise plays a pivotal role in the optimization of mental health, but there is little evidence available to demonstrate its effects on women with PCOS. So, this study has been designed to study the effects of structured aerobics exercise programs on the mental and physical health of women with PCOS.

Conditions

  • Polycystic Ovary Syndrome

Interventions

OTHER

Structured aerobics exercise

A 12 week structured aerobics exercise program will be offered. The patient has to perform exercise five times a week , 30 minutes a day

Sponsors & Collaborators

  • Muhammad Irfan

    lead OTHER

Principal Investigators

  • Rabia Kareem, MBBS,FCPS · Peshawar Medical College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2023-03-31
Completion
2023-04-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05577949 on ClinicalTrials.gov